Pro-Dex, Inc. (PDEX)
NASDAQ: PDEX · Real-Time Price · USD
32.69
-1.12 (-3.31%)
At close: Sep 17, 2025, 4:00 PM EDT
32.75
+0.06 (0.18%)
Pre-market: Sep 18, 2025, 7:41 AM EDT
Pro-Dex Market Cap
Pro-Dex has a market cap or net worth of $106.63 million as of September 18, 2025. Its market cap has increased by 33.63% in one year.
Market Cap
106.63M
Enterprise Value
115.90M
1-Year Change
33.63%
Ranking
Category
Stock Price
$32.69
Market Cap Chart
Since December 1, 1998, Pro-Dex's market cap has increased from $18.70M to $106.63M, an increase of 470.24%. That is a compound annual growth rate of 6.71%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 17, 2025 | 106.60M | -30.05% |
Dec 31, 2024 | 152.40M | 145.41% |
Dec 29, 2023 | 62.10M | 9.14% |
Dec 30, 2022 | 56.90M | -33.06% |
Dec 31, 2021 | 85.00M | -28.87% |
Dec 31, 2020 | 119.50M | 71.45% |
Dec 31, 2019 | 69.70M | 36.40% |
Dec 31, 2018 | 51.10M | 72.05% |
Dec 29, 2017 | 29.70M | 55.50% |
Dec 30, 2016 | 19.10M | 91.00% |
Dec 31, 2015 | 10.00M | -2.91% |
Dec 31, 2014 | 10.30M | 27.16% |
Dec 31, 2013 | 8.10M | 19.12% |
Dec 31, 2012 | 6.80M | -16.05% |
Dec 30, 2011 | 8.10M | 24.62% |
Dec 31, 2010 | 6.50M | 32.65% |
Dec 31, 2009 | 4.90M | 16.67% |
Dec 31, 2008 | 4.20M | -70.21% |
Dec 31, 2007 | 14.10M | 2.17% |
Dec 29, 2006 | 13.80M | -40.77% |
Dec 30, 2005 | 23.30M | -6.43% |
Dec 31, 2004 | 24.90M | -9.78% |
Dec 31, 2003 | 27.60M | 590.00% |
Dec 31, 2002 | 4.00M | -44.44% |
Dec 31, 2001 | 7.20M | -71.54% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 682.40B |
Johnson & Johnson | 426.76B |
AbbVie | 390.07B |
UnitedHealth Group | 309.39B |
Novo Nordisk | 260.64B |
AstraZeneca | 241.43B |
Novartis AG | 237.64B |
Abbott Laboratories | 233.52B |